Paper288488
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.
Gallagher R and 10 others. Blood, 1979. Cited by 929 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Papers, record 288488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/288488
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
| Database | Record | Link | It holds |
|---|---|---|---|
| cell-lines | HL-60 | Cellosaurus cites the paper | 194 papers |
Source Cell lines
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Line | Major topic |
| Adult | |
| Bone Marrow | |
| Chromosomes, Human | |
| Female | |
| Histocytochemistry | |
| Humans | |
| Karyotyping | |
| Leukemia, Myeloid, Acute | |
| Microscopy, Electron | |
| Phenotype | |
| Receptors, Antigen, B-Cell | |
| Rosette Formation |
Source PubMed
Cited by259
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 929 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,329,216 | An optimized method to differentiate HL60 cells into neutrophil-like cells. | J Leukoc Biol | 2026 | https://conductscience.org/library/papers/42329216 | PubMed |
| 42,195,116 | Next-Generation In Vitro Pulmonary Platforms for Respiratory Disease Modelling and Therapeutic Development: Current Advances and Future Prospects. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42195116 | PubMed |
| 41,898,298 | Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898298 | PubMed |
| 41,767,897 | Utilizing High-Throughput Screening of dHL-60 Inflammatory Behaviors to Evaluate Honey-Derived Molecules' Potential as Immunomodulatory Biomaterial Additives. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41767897 | PubMed |
| 41,750,262 | Phytochemicals Possess Selective Chemopreventive Mechanisms That Safeguard Human Cells from Oxidative Toxicity. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750262 | PubMed |
| 41,542,487 | AN OPTIMIZED METHOD TO DIFFERENTIATE HL60 CELLS INTO NEUTROPHIL-LIKE CELLS. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542487 | PubMed |
| 41,227,366 | Acute Myeloid Leukemia: A Key Role of DGKα and DGKζ in Cell Viability. | Cells | 2025 | https://conductscience.org/library/papers/41227366 | PubMed |
| 41,208,847 | Understanding the Role of All-Trans Retinoic Acid in Acute Myeloid Leukemia Cells. | World J Oncol | 2025 | https://conductscience.org/library/papers/41208847 | PubMed |
| 41,048,723 | Exploring Regioisomeric Indole-Furanone Tubulin Inhibitors. | ACS Omega | 2025 | https://conductscience.org/library/papers/41048723 | PubMed |
| 40,909,285 | Comprehensive review of macrophage models: primary cells and immortalized lines across species. | Front Immunol | 2025 | https://conductscience.org/library/papers/40909285 | PubMed |
| 40,863,625 | Marine-Inspired Ovothiol Analogs Inhibit Membrane-Bound Gamma-Glutamyl-Transpeptidase and Modulate Reactive Oxygen Species and Glutathione Levels in Human Leukemic Cells. | Mar Drugs | 2025 | https://conductscience.org/library/papers/40863625 | PubMed |
| 40,598,376 | Mechanical force-induced oncostatin M secretion by Jun-positive neutrophils promotes craniofacial bone regeneration for midface hypoplasia treatment. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40598376 | PubMed |
| 40,377,133 | Potent Therapeutic Activity of NEO212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma. | Vet Comp Oncol | 2025 | https://conductscience.org/library/papers/40377133 | PubMed |
| 40,116,400 | FGR Src family kinase causes signaling and phenotypic shift mimicking retinoic acid-induced differentiation of leukemic cells. | Oncotarget | 2025 | https://conductscience.org/library/papers/40116400 | PubMed |
| 39,830,209 | In Vitro models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39830209 | PubMed |
| 39,683,053 | In Vivo and In Vitro Studies Assessing the Safety of Monosodium Glutamate. | Foods | 2024 | https://conductscience.org/library/papers/39683053 | PubMed |
| 39,548,727 | Biochemical characterization of the human ubiquitous glucose-6-phosphatase in neutrophil granulocytes. | FEBS Open Bio | 2025 | https://conductscience.org/library/papers/39548727 | PubMed |
| 39,082,351 | Methyl Syringate: A Primary Driving Factor in Manuka Honeys Ability to Ameliorate Neutrophil Intracellular ROS Activity and NETosis. | Front Biosci (Landmark Ed) | 2024 | https://conductscience.org/library/papers/39082351 | PubMed |
| 38,892,520 | Serum-Derived Bovine Immunoglobulin Promotes Barrier Integrity and Lowers Inflammation for 24 Human Adults Ex Vivo. | Nutrients | 2024 | https://conductscience.org/library/papers/38892520 | PubMed |
| 38,673,926 | Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673926 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/288488
GET https://conductscience.org/api/papers/v1/288488/cited_by?page=2